Publication:
Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet).

Loading...
Thumbnail Image

Date

2020-04-29

Authors

Locati, Laura
Cavalieri, Stefano
Dal Maso, Luigino
Busco, Susanna
Anderson, Lesley Ann
Botta, Laura
Bento, Maria Jose
Carulla, Maria
Chirlaque Lopez, Maria Dolores
Fusco, Mario

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier Ltd
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Limited information is available on the incidence of rare thyroid cancer (TC) subtypes: anaplastic (ATC) and medullary (MTC). The aim of this study was to describe incidence variations and trends across European countries of all TC subtypes. We used the RARECAREnet database including 80721 TC incident cases in the period 2000-2007 from 77 population-based cancer registries (CRs) in Europe. In the trend analyses, we included 68890 TC cases from 53 CRs with at least 6 years of incidence data in the years 2000-2007. In Europe age-standardised incidence rates (ASR) in women were The huge increase and heterogeneity between countries of PTC incidence has a small influence on the trends and variations of MTC and ATC in Europe. Large-scale epidemiological and clinical registry-based studies are warranted to increase knowledge about the rarest TC subtypes. This information would be fundamental for the design of new clinical trials and for inference.

Description

MeSH Terms

Databases, Factual
Europe
Female
Humans
Male
Rare Diseases
Registries
Thyroid Neoplasms

DeCS Terms

Bases de datos factuales
Enfermedades raras
Europa (Continente)
Femenino
Humanos
Masculino
Neoplasias de la tiroides
Sistema de registros

CIE Terms

Keywords

Anaplastic thyroid cancer, Cancer registries, Epidemiology, Incidence, Medullary thyroid cancer, Thyroid cancer

Citation

Locati L, Cavalieri S, Dal Maso L, Busco S, Anderson LA, Botta L, et al. Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet). Oral Oncol. 2020 Sep;108:104766.